Already have an account? Sign in.
Oruka Therapeutics Stock Surges on Rival's Mixed Drug Trial Results
Oruka Therapeutics shares jump 30% as analysts predict gains following competitor MoonLake's Phase 3 results.
Oruka Therapeutics shares jump 30% as analysts predict gains following competitor MoonLake's Phase 3 results.
SpaceX’s Starship upper stage returned from a 22-hour orbital mission and was caught by the launch tower for the first time, marking a key reusability milestone.
The Financial Times reports Amazon is the hyperscaler behind Fermi America’s new 600 MW power deals following the breakdown of 2025 talks.
Meta’s internal prediction market app Takes lets employees bet with credibility points instead of cash. Launch plans remain unclear.
Be the first to know when deals break, stocks move, or biotech headlines hit.